![]() |
市场调查报告书
商品编码
1348455
无针接头的全球市场:规模,占有率,趋势分析(2024年~2030年):MedCoreNeedleless Connector Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Hospital NLCs and Non-Hospital NLCs |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年,全球无针连接器市场规模预计将达到13.3亿美元,较上年的12.6亿美元成长5.8%。展望未来,预计将以4.5%的复合年增长率(CAGR)实现稳定成长,最终达到18亿美元。值得注意的是,Becton Dickinson (BD) 和 ICU Medical 目前在全球无针连接器市场占主导地位。
在接下来的预测期内,新兴市场将受益于逐步转向机械阀门设备。儘管用于机械瓣膜的无针连接器 (NLC) 的某些配置仍然存在一些问题,但其中大量已证明可改善患者的整体治疗效果。儘管这些设备通常比分体式隔膜产品稍贵,但机械阀 NLC 的日益普及预计将在未来几年对整体市场价值产生积极影响。
2023 年,Becton Dickinson (BD) 巩固了其无针连接器 (NLC) 市场全球领导者的地位。该公司在广阔的输液治疗市场中占主导地位,增强了其品牌知名度以及以具有竞争力的价格大量生产和销售各种一次性产品的能力。
ICU医疗在2023年稳居无针连接器市场第二名。在机械阀门连接器领域,ICU Medical 提供 Clave(TM) 连接器。Clave(TM) 连接器的创新设计将外部钝插管无缝整合到分离式隔垫结构中,确保与任何标准公鲁尔连接器相容。
无针连接器与各种其他一次性医疗保健产品一样,可以以相对较低的成本製造和销售。这为中小企业进入市场提供了动力,旨在提供与大公司相比更简单、更具成本效益的产品。也就是说,能够将 NLC 产品与其他输液治疗设备捆绑在一起的公司预计将在预测期内主导该市场。
本报告提供全球无针接头市场相关调查,提供市场概要,以及各市场区隔,各地区趋势,竞争情形等资讯。
In 2023, the worldwide needleless connector market exhibited a total worth of $1.33 billion, reflecting a 5.8% surge compared to the previous year's $1.26 billion. Projections for the upcoming period indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 4.5%, ultimately reaching $1.80 billion. Notably, Becton Dickinson (BD) and ICU Medical are currently the dominant players in the global needleless connector market.
Our comprehensive medical market research involved an extensive analysis of more than 15 intravenous set companies spanning seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts. The full report suite on the global intravenous sets market encompasses both hospital NLCs and non-hospital NLCs.
In the upcoming forecast period, emerging markets are set to reap the benefits of a gradual shift towards mechanical valve devices. Although certain configurations of mechanical valve needleless connectors (NLCs) raise some concerns, a significant number of them have proven their capability to enhance overall patient outcomes. Even though these devices typically come with a slightly higher price tag compared to split septum products, the increasing adoption of mechanical valve NLCs is expected to yield a favorable impact on the overall market's value in the years to come.
In 2023, Becton Dickinson (BD) solidified its position as the global leader in the Needleless Connector (NLC) market. Notably, Becton Dickinson also functions as an infusion pump manufacturer, leveraging this capability to bundle NLCs with its devices. The company maintains a commanding presence in the broader infusion therapy market, bolstering both its brand recognition and the ability to manufacture and market various disposable products in significant quantities at competitive prices.
Securing the second position in the global NLC market in 2023 was ICU Medical. In the realm of mechanical valve connectors, ICU Medical offers the Clave™ connector. The Clave™ connector's innovative design seamlessly integrates the external blunt cannula into the split septum structure, ensuring compatibility with any standard male Luer connector.
Needleless connectors, much like various other disposable healthcare products, can be produced and sold at relatively low costs. This aspect serves as an incentive for smaller companies to enter the market, aiming to provide simpler and more cost-effective products compared to their larger counterparts. Nonetheless, throughout the forecast period, the dominant players in this market are expected to be those capable of bundling NLC products with other infusion therapy devices.